|
Powered by Cell Signaling Technology |
|
Powered by Cell Signaling Technology |
| Site Information |
|---|
| QDtYRRNsVRFLQQR SwissProt Entrez-Gene |
| Blast this site against: NCBI SwissProt PDB |
| Site Group ID: 449404 |
| In vivo Characterization | |
|---|---|
| Methods used to characterize site in vivo: | |
| Relevant cell line - cell type - tissue: | |
| Upstream Regulation | |
|---|---|
| Putative in vivo kinases: | |
| Kinases, in vitro: | |
| Treatments: | |
| Downstream Regulation | |
|---|---|
| Effects of modification on p47phox: | |
| References | |
|---|---|
|
Sun L, et al. (2018) A Role for MK2 in Enhancing Neutrophil-Derived ROS Production and Aggravating Liver Ischemia/Reperfusion Injury. Front Immunol 9, 2610
30483268 Curated Info |
|
|
Jennings RT, et al. (2014) RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness. Blood 123, 3635-45
24782506 Curated Info |
